Sutro Biopharma, Inc. (STRO) — DEFA14A Filings

All DEFA14A filings from Sutro Biopharma, Inc.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.

DEFA14A Filings (1)

  • Sutro Biopharma Files Proxy Supplement — May 17, 2024 Risk: low
    Sutro Biopharma, Inc. filed a supplemental proxy statement on May 17, 2024, to its definitive proxy statement dated April 29, 2024. This filing is related to th

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.